MedTrace Logo

Portable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease

NCT01026207 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2013-10-23

No results posted yet for this study

Summary

Introduction:

The prevalence of overlap between Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea Syndrome (OSAS) is around 10%. This overlap syndrome is an important issue because is related to nocturnal desaturation and its complications. The use of portable monitoring devices (PM) for the diagnosis of OSAS was recently accepted as an alternative to full-night polysomnography (PSG). However, there are not studies evaluating the PM recording in COPD patients to detect or exclude OSAS.

Objective:

To evaluate if a PM (Stardust®, Respironics, Inc, USA) could accurately measure the apnea-hypopnea index (AHI) in COPD patients with a suspicion of OSAS.

Conditions

Interventions

DEVICE

Polysomnography

Sleep study polysomnography compared with portable monitoring

Sponsors & Collaborators

  • Federal University of São Paulo

    collaborator OTHER

  • Associação Fundo de Incentivo à Pesquisa

    lead OTHER

Principal Investigators

  • Lia A Bittencourt, PhD · Federal University of São Paulo

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026207 on ClinicalTrials.gov